These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 4879138)

  • 1. [Progressive scleroderma and the terminal stage of malignant hypertension].
    Schäfer HE; Schäfer A
    Arch Klin Med; 1968; 214(3):187-200. PubMed ID: 4879138
    [No Abstract]   [Full Text] [Related]  

  • 2. End stage renal failure with syndrome of "malignant" hypertension in scleroderma. Report of a case treated by bilateral nephrectomy.
    Sessa A; Cioffi A; Conte F; Conti U; Giordano F; Di Ruscio A; Vegeto A
    Pathologica; 1976; 68(981-982):355-9. PubMed ID: 1018990
    [No Abstract]   [Full Text] [Related]  

  • 3. [Sclerotic ring around the renal artery in scleroderma--malignant hypertension].
    Bergentz SE; Hood B; Stakeberg H
    Lakartidningen; 1968 Oct; 65(43):4216-8. PubMed ID: 5741907
    [No Abstract]   [Full Text] [Related]  

  • 4. Malignant hypertension and renal failure: scleroderma renal crisis or renal artery stenosis?
    Morris K; Connolly JO; O'Donnell PJ; Scoble JE
    Nephrol Dial Transplant; 1994; 9(10):1489-91. PubMed ID: 7816267
    [No Abstract]   [Full Text] [Related]  

  • 5. [Malignant hypertension in progressive scleroderma].
    Fladerer H; Klein G
    Z Rheumaforsch; 1972; 31(5):185-90. PubMed ID: 5048145
    [No Abstract]   [Full Text] [Related]  

  • 6. [Scleroderma causing ureteral occlusion (progressive systemic sclerosis)].
    Korom I; Sonkodi S; Ormos J
    Orv Hetil; 1973 May; 114(19):1119-21. PubMed ID: 4699764
    [No Abstract]   [Full Text] [Related]  

  • 7. [A case of the successful treatment of true scleroderma kidney].
    Nikolaev AIu; Milovanov IuS; Bezruk VG; Trofimova EI; Dzgoeva FU
    Klin Med (Mosk); 1995; 73(3):104-5. PubMed ID: 8577092
    [No Abstract]   [Full Text] [Related]  

  • 8. [Renal involvement in progressive systemic sclerosis (PSS)].
    Kondo H; Yanagida K; Uchida K; Kashiwazaki S
    Ryumachi; 1982 Aug; 22(4):293-300. PubMed ID: 6758144
    [No Abstract]   [Full Text] [Related]  

  • 9. Reversible acute renal faiure in diffuse scleroderma.
    Ponticelli C; Ambroso G; Graziani G; Rossi E
    Clin Nephrol; 1980 Jun; 13(6):293-5. PubMed ID: 7408249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunologic studies in sclerodermia].
    Jablonska S; Chorzelski T
    Allerg Immunol (Leipz); 1972; 18(3):187-90. PubMed ID: 4269352
    [No Abstract]   [Full Text] [Related]  

  • 11. [Scleroderma renal crisis (SRC): hypertensive, normotensive].
    Endo H
    Nihon Rinsho Meneki Gakkai Kaishi; 2000 Dec; 23(6):656-60. PubMed ID: 11210764
    [No Abstract]   [Full Text] [Related]  

  • 12. [Improvement in scleroderma kidney with captopril].
    Ben David A; Blau A; Rapoport G
    Harefuah; 1994 Oct; 127(7-8):234-5, 287. PubMed ID: 7813949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Malignant arterial hypertension in scleroderma. Beneficial effects of captopril on pulmonary and systemic vascular resistance].
    Bonnet F; Matamis D; Lepresle E; Cabane J; Le Gall JR
    Nouv Presse Med; 1982 May; 11(20):1570-1. PubMed ID: 7048249
    [No Abstract]   [Full Text] [Related]  

  • 14. Hypertension and vascular diseases of the kidney.
    Heptinstall RH
    Monogr Pathol; 1979; 20():281-94. PubMed ID: 388205
    [No Abstract]   [Full Text] [Related]  

  • 15. Direct immunofluorescent findings in scleroderma syndromes.
    Connolly SM; Winkelmann RK
    Acta Derm Venereol; 1981; 61(1):29-36. PubMed ID: 6164211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Importance of certain laboratory indicators for determination of the activity of systemic scleroderma].
    Shiapak EA; Drampian FS; Kessel' VP; Aznaurian AV; Lobanova IN
    Zh Eksp Klin Med; 1973; 13(3):96-100. PubMed ID: 4599068
    [No Abstract]   [Full Text] [Related]  

  • 17. Resolution of renal failure with malignant hypertension in scleroderma. Case report and review of the literature.
    Simon NM; Graham MB; Kyser FA; Gashti EN
    Am J Med; 1979 Sep; 67(3):533-9. PubMed ID: 474603
    [No Abstract]   [Full Text] [Related]  

  • 18. Characterization of immunoglobulin G anti-glomerular basement membrane antibodies eluted from kidneys of patients with glomerulonephritis. II. IgG subtypes and in vitro complement fixation.
    McPhaul JJ; Dixon FJ
    J Immunol; 1971 Sep; 107(3):678-84. PubMed ID: 4999091
    [No Abstract]   [Full Text] [Related]  

  • 19. [Diagnosis of the primary visceral form of scleroderma].
    Atefie K; Gschnait F; Steinbach K
    Wien Z Inn Med; 1973; 54(8-9):352-5. PubMed ID: 4803612
    [No Abstract]   [Full Text] [Related]  

  • 20. [Resolution of scleroderma renal crisis with thrombotic microangiopathy. Case report (author's transl)].
    Rebaiz K; Birembaut P; Charneau A; Petit J; Wolf C
    Nephrologie; 1980; 1(3):137-41. PubMed ID: 7027064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.